These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3655310)

  • 1. Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatment.
    Scully LJ; Shein R; Karayiannis P; McDonald JA; Thomas HC
    J Hepatol; 1987 Aug; 5(1):51-8. PubMed ID: 3655310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection.
    Brook MG; Main J; Yap I; Chan G; Karayiannis P; Crossey M; Thomas HC
    Aliment Pharmacol Ther; 1993 Jun; 7(3):331-6. PubMed ID: 8364139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon.
    Hess G; Meyer zum Büschenfelde KH
    Immunobiology; 1986 Sep; 172(3-5):255-61. PubMed ID: 3643162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.
    Krogsgaard K; Marcellin P; Trepo C; Berthelot P; Sanchez-Tapias JM; Bassendine M; Tran A; Ouzan D; Ring-Larsen H; Lindberg J; Enriquez J; Benhamou JP; Bindslev N
    J Hepatol; 1996 Dec; 25(6):803-13. PubMed ID: 9007706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.
    Janssen HL; Berk L; Schalm SW; Heijtink RA; Hess G; Rossol S; Meyer zum Buschenfelde KH; Chamuleau RA; Jansen PL; Reesink HW
    Gut; 1992 Aug; 33(8):1094-8. PubMed ID: 1398234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
    Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
    Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.
    Brook MG; Chan G; Yap I; Karayiannis P; Lever AM; Jacyna M; Main J; Thomas HC
    BMJ; 1989 Sep; 299(6700):652-6. PubMed ID: 2508850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
    Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients.
    Alexander GJ; Fagan EA; Guarner P; Rolando N; Brahm J; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S183-8. PubMed ID: 3298406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors.
    Brook MG; Karayiannis P; Thomas HC
    Hepatology; 1989 Nov; 10(5):761-3. PubMed ID: 2680866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of protracted acute type B hepatitis with recombinant alpha-A-interferon. A pilot study.
    Hess G; Rossol S; Voth R; Weber C; Drees N; Meyer zum Büschenfelde KH
    J Hepatol; 1989 Jan; 8(1):73-6. PubMed ID: 2921506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).
    Krogsgaard K; Bindslev N; Christensen E; Craxi A; Schlichting P; Schalm S; Carreno V; Trepo C; Gerken G; Thomas HC
    J Hepatol; 1994 Oct; 21(4):646-55. PubMed ID: 7814812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
    McDonald JA; Caruso L; Karayiannis P; Scully LJ; Harris JR; Forster GE; Thomas HC
    Hepatology; 1987; 7(4):719-23. PubMed ID: 3038722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
    Lai CL; Lok AS; Lin HJ; Wu PC; Yeoh EK; Yeung CY
    Lancet; 1987 Oct; 2(8564):877-80. PubMed ID: 2889081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
    Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.